CARDIOVASCULAR DISEASES

You have access
Choice of Biologic Immunotherapy for Psoriasis or Psoriatic Arthritis and Its Association With Risk of Major Adverse Cardiac Events
Jack Geiger, Bonit Gill, Jean Liew, Michael Putman and Shikha Singla

The Journal of Rheumatology March 1 2026, 53 (3) 277-282; DOI: https://doi.org/10.3899/jrheum.2025-0446
You have access
How to Manage Cardiovascular Disease in Psoriatic Disease: Evidence and Time Management in Clinic
Maria-Angeliki Gkini, Pamela Díaz, Cheryl F. Rosen and Claudia Goldenstein-Schainberg

The Journal of Rheumatology December 1 2025, 52 (Suppl 3) 49-51; DOI: https://doi.org/10.3899/jrheum.2025-0811
You have access
Circulating Interleukin 17A and Other Inflammatory Proteins May Predict Cardiovascular Disease in Early Rheumatoid Arthritis
Emil Rydell, Lennart T.H. Jacobsson and Carl Turesson

The Journal of Rheumatology August 1 2024, 51 (8) 752-758; DOI: https://doi.org/10.3899/jrheum.2023-1078
You have access
Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis–Associated Interstitial Lung Disease
Jessica L. Fairley, Dylan Hansen, Andrew Burns, David Prior, André La Gerche, Kathleen Morrisroe, Wendy Stevens, Mandana Nikpour and Laura J. Ross

The Journal of Rheumatology May 1 2024, 51 (5) 495-504; DOI: https://doi.org/10.3899/jrheum.2023-0801
Open Access
Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib
Christina Charles-Schoeman, Craig Hyde, Shunjie Guan, Neil Parikh, Jennifer Wang, Ani Shahbazian, Lori Stockert and John Andrews

The Journal of Rheumatology December 1 2023, 50 (12) 1573-1580; DOI: https://doi.org/10.3899/jrheum.2023-0112
You have access
Examining the Characteristics of Colchicine-Induced Myelosuppression in Clinical Cases: A Systematic Review
Bernice L. Sim, Beatrice Z. Sim, Matthew Tunbridge, David F.L. Liew and Philip C. Robinson

The Journal of Rheumatology March 1 2023, 50 (3) 400-407; DOI: https://doi.org/10.3899/jrheum.220524
You have access
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort
Jean W. Liew, S. Reza Jafarzadeh, Maureen Dubreuil, Susan R. Heckbert, Stephen J. Mooney, Matthew A. Brown, Mariko L. Ishimori, John D. Reveille, Michael M. Ward, Michael H. Weisman and Lianne S. Gensler

The Journal of Rheumatology March 1 2022, 49 (3) 274-280; DOI: https://doi.org/10.3899/jrheum.210332
You have access
Long-term Risk of Heart Failure and Other Adverse Cardiovascular Outcomes in Granulomatosis With Polyangiitis: A Nationwide Cohort Study
Guoli Sun, Adelina Yafasova, Bo Baslund, Mikkel Faurschou, Morten Schou, Abdulrahman N. Shams-Eldin, Søren Lund Kristensen, Peter E. Weeke, Christian Torp-Pedersen, Emil L. Fosbøl, Lars Køber and Jawad H. Butt

The Journal of Rheumatology March 1 2022, 49 (3) 291-298; DOI: https://doi.org/10.3899/jrheum.210677
Open Access
Improved Incidence of Cardiovascular Disease in Patients With Incident Rheumatoid Arthritis in the 2000s: A Population-based Cohort Study
Elena Myasoedova, John M. Davis, Veronique L. Roger, Sara J. Achenbach and Cynthia S. Crowson

The Journal of Rheumatology September 1 2021, 48 (9) 1379-1387; DOI: https://doi.org/10.3899/jrheum.200842
You have access
Quality of Care in Childhood-onset Systemic Lupus Erythematosus: Report of an Intervention to Improve Cardiovascular and Bone Health Screening
Emily A. Smitherman, Bin Huang, Adam Furnier, Janalee Taylor, Mary Beth Burns, Hermine I. Brunner and Esi M. Morgan

The Journal of Rheumatology October 1 2020, 47 (10) 1506-1513; DOI: https://doi.org/10.3899/jrheum.190295

Main menu

User menu

Search

CARDIOVASCULAR DISEASES

Pages

Content

Resources

Subscribers

More